These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1413633)

  • 1. [Prostacyclin-thromboxane system in children and adolescents with a high risk of developing ischemic heart disease].
    Akimova EV
    Vopr Med Khim; 1992; 38(2):47-9. PubMed ID: 1413633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Phenotypic familial correlations of prostacyclin and thromboxane A2 levels in children and adolescents with or without hereditary predisposition to ischemic heart disease].
    Akimov EV
    Kardiologiia; 1992 May; 32(5):41-3. PubMed ID: 1405259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostacyclin and thromboxane levels of children of parents suffering from early ischemic heart disease.
    Mihai K; Petó J; Kolthay E; Makáry A
    Acta Paediatr Hung; 1991; 31(1):113-8. PubMed ID: 1867870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of the calcium antagonist diltiazem on the prostacyclin-thromboxane ratio in the plasma of ischemic heart disease patients].
    Brovkovich VM; Topchiĭ II; Abidov AA
    Vopr Med Khim; 1991; 37(2):37-9. PubMed ID: 1897189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The prostacyclin-thromboxane system and the functional properties of the thrombocytes in patients of different ages with ischemic heart disease].
    Ermakovich II; Ladnyĭ AI; Volkov VI; Tseluĭko VI
    Vrach Delo; 1990 Sep; (9):25-8. PubMed ID: 2284757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostacyclin and thromboxane A2 levels in children and adolescents with an inherited predisposition to coronary heart disease: a family study.
    Akimova EV
    Coron Artery Dis; 1994 Sep; 5(9):761-5. PubMed ID: 7858766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The prostacyclin-thromboxane system and thrombocytic-vascular hemostasis in patients with ischemic heart disease in the preoperative period].
    Abbakumov VV; Vinnitskiĭ LI; Kattakhanova RIu; Studennikova LN; Egorova IA; Smirnova LA
    Anesteziol Reanimatol; 1992; (1):42-4. PubMed ID: 1524251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasma prostacyclin and thromboxane concentration in healthy children and in offspring of parents suffering from myocardial infarct].
    Mihai K; Petö J; Kolthay E; Makáry A; Timár S; Lusztig G
    Orv Hetil; 1991 Jul; 132(30):1627-9. PubMed ID: 1866156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Kinetics of thromboxane A2 and prostacyclin during reperfusion after induced ischemia in canine hearts].
    Nomura F; Hirose H; Matsuda H; Nakano S; Shirakura R; Ohtani M; Kaneko M; Sasako Y; Kawashima Y; Kuzuya T
    Kyobu Geka; 1985 Jan; 38(1):46-9. PubMed ID: 3884863
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostacyclin and thromboxane levels during cardiac ischemia in dogs.
    Prosdocimi M; Tessari F; Finesso M; Gorio A; Dejana E; Languino LR; Del Maschio A; de Gaetano G
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():93-6. PubMed ID: 3159235
    [No Abstract]   [Full Text] [Related]  

  • 11. [Status of the prostacyclin-thromboxane A2 system in patients with ischemic heart disease during induced myocardial ischemia].
    Nikolaeva LF; Aleshin OI; Pavlov NA; Pomerantsev EV; Masenko VP
    Sov Med; 1988; (4):3-6. PubMed ID: 3043710
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of nitrates and miskleron on the prostacyclin-thromboxane ratio and on the functional activity of the thrombocytes in stenocardia patients].
    Volkov VI; Ladnyĭ AI
    Vrach Delo; 1989 Nov; (11):60-2. PubMed ID: 2514486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dynamics of the indices of the prostacyclin-thromboxane system in adolescents with hypotensive type vegetovascular dysfunction exposed to hyperbaric oxygenation].
    Buriak VN; Prokhorov EV; Kravtsov PIa
    Lik Sprava; 2001; (5-6):80-3. PubMed ID: 11881389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid peroxides, prostacyclin, and thromboxane A2 in runners during acute exercise.
    Viinikka L; Vuori J; Ylikorkala O
    Med Sci Sports Exerc; 1984 Jun; 16(3):275-7. PubMed ID: 6379367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of selective thromboxane synthetase inhibitor and indomethacin on prostacyclin and thromboxane A2 from ischemic canine heart.
    Ogawa K; Sakai K; Ito T; Watanabe J; Satake T
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():371-6. PubMed ID: 6221548
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes of thromboxane A2 and prostacyclin in the pregnant hypertensive syndrome].
    Shen XY
    Zhonghua Yi Xue Za Zhi; 1984 Dec; 64(12):735-7, 790. PubMed ID: 6443193
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changes in the prostacyclin-thromboxane system at the early stages of arterial hypertension].
    Dias RT
    Vrach Delo; 1987 Mar; (3):38-9. PubMed ID: 3296447
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of the complex treatment of stable stenocardia on the status of the prostacyclin-thromboxane system].
    Khimenko PL
    Ter Arkh; 1986; 58(5):95-8. PubMed ID: 2874621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thromboxane A2 and prostacyclin in patients with chronic glomerulonephritis and coronary heart disease in contrast media nephrotoxicity. Protective effects of calcium antagonists].
    Dzgoeva FU; Kutyrina IM
    Ter Arkh; 2000; 72(6):42-5. PubMed ID: 10900648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Des-amino-D-arginine vasopressin does not increase circulating levels of prostacyclin or thromboxane A2 during infusion in man.
    Barrow SE; Heavey DJ; Jacqz E; Blair IA; Dollery CT
    Thromb Haemost; 1983 Aug; 50(2):622. PubMed ID: 6356457
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.